COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)
$35.23 -0.58 (-1.6197%)
Analysed COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) News Sources
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05-06-2026
yahoo.com
3 of Wall Street’s Favorite Stocks We Approach with Caution
19-06-2026
yahoo.com
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
23-06-2026
yahoo.com
Bull of the Day: Neurocrine Biosciences (NBIX)
29-06-2026
yahoo.com
Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why
01-07-2026
yahoo.com
2 Profitable Stocks to Keep an Eye On and 1 We Brush Off
02-07-2026
yahoo.com
1 Mooning Stock to Own for Decades and 2 That Underwhelm
03-07-2026
yahoo.com
1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
07-07-2026
yahoo.com
4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues
08-07-2026
yahoo.com
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?
09-07-2026
yahoo.com
What is the current price of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The current price of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is $35.23.
COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) absolute price change since previous trading day?
The absolute price change of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) since the previous trading day is $-0.58.
COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) percentage price change since previous trading day?
The percentage price change of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) since the previous trading day is -1.6197%.
What is the most recent average sentiment score for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The most recent average sentiment score for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The most recent sentiment for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is .
SEC-8K** Filing Available For COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.